| Metric | სს ბიოფარმი | შპს ბიოპოლუსი | სს ინოვას |
|---|---|---|---|
| Growth | |||
| Revenue | ₾10.1m₾9.7m | ₾6.5m₾12.8m | ₾5.0m₾1.9m |
| Revenue growth | 4.8% | -49.1% | 165.0% |
| Profitability | |||
| EBITDA | -₾847k-₾427k | ₾1.9m₾3.4m | ₾2.8m₾549k |
| EBITDA margin | -8.3%-4.4% | 29.2%26.7% | 56.5%29.1% |
| Net profit | -₾1.3m-₾1.1m | ₾1.5m₾3.4m | ₾2.7m₾378k |
| Net margin | -12.6%-11.5% | 23.6%26.3% | 54.8%20.0% |
| Balance sheet | |||
| Total assets | ₾19.1m₾18.5m | ₾14.7m₾13.6m | ₾6.3m₾4.0m |
| Total equity | ₾18.2m₾17.1m | ₾11.7m₾10.2m | ₾5.5m₾3.2m |
| ROE | -7.0%-6.5% | 13.1%33.0% | 49.8%11.7% |